RACHEL KERN
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
JESSE BLAND,
AMANDA BRINGE,
PAT CLINE,
PATRICK CLINE,
TAYLOR CLINE,
KIRK CLOVE,
CHRISTOPHER DOOLEY,
MATT ETHERIDGE,
MATTHEW ETHERIDGE,
RICHARD FRANK,
DYLAN HERR,
MICHAEL HOLOHAN,
JAMES HOXTER,
ROCK MORPHIS,
DEVRAJ MUKHERJEE,
JON PHILLIPS,
JONATHAN PHILLIPS,
BARTHO VAN OTTERDYK,
SCOTT WADDELL,
CHRISTOPHER WOOLEY
DIRECTOR
RUSH BARTLETT,
RUSH L. BARTLETT II,
JAMES P. BRADLEY,
ARNIE BURCHIANTI,
ARNOLD E. BURCHIANTI, II,
PHILLIP FOGG JR.,
RUSSELL HIRSCH,
JOE MANDATO,
AABED MEER,
DARREN SCHULTE,
H. BRADLEY SLOAN,
H. BRADLEY SLOAN,
FRANK SPARACINO,
KATHRYN THOMAS,
RYAN VAN WERT
DIRECTOR
LUCAS BARAN,
LEO BRUBAKER,
JAMISON FERAMISCO,
KATY FIKE,
ROBERT GONSALVES,
DAN HERBSTMAN,
DANIEL HERBSTMAN,
RUSSELL HIRSCH,
STEFAN LEFAR,
STEVE LEFAR,
STEVEN LEFAR,
KIRSTEN MORBECK,
KRISTIN MORBECK,
AMISH PATEL,
DAVID REIS,
MICHAEL SACHS,
MARY KATE SALLEY,
YAAKOV SPINRAD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
POOLED INVESTMENT FUND
DECLINE TO DISCLOSE
Equity
2026-01-30
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2024-01-27
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2023-12-27
D/A
OTHER
DECLINE TO DISCLOSE
Equity
2024-07-25
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2023-12-27
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2024-01-27
D
POOLED INVESTMENT FUND
DECLINE TO DISCLOSE
Equity
2024-10-04
D
OTHER
DECLINE TO DISCLOSE
Equity
2024-07-25
D/A
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2023-08-24
D
OTHER TRAVEL
DECLINE TO DISCLOSE
Equity
2024-04-15
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2024-01-27
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2023-09-06
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2023-08-24
D
OTHER TRAVEL
DECLINE TO DISCLOSE
Equity
2022-10-19
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2022-09-30
D
OTHER
DECLINE TO DISCLOSE
Equity
2022-07-25
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2021-12-23
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2020-10-14
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2020-10-14